Antimicrobial properties of amniotic membrane

British Journal of Ophthalmology

Volumn 95, Issue 1, 2011, Pages 1-2

  Sangwan, Virender S ^a   Basu, Sayan ^a  

^a L V PRASAD EYE INSTITUTE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; GELATINASE B; NETILMICIN; NEUTROPHIL COLLAGENASE; TISSUE INHIBITOR OF METALLOPROTEINASE 1; TISSUE INHIBITOR OF METALLOPROTEINASE 2; TRIFLURIDINE;

AMNION; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; DOSE RESPONSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG ELIMINATION; EDITORIAL; HUMAN; NONHUMAN; PRIORITY JOURNAL;

AMNION; CORNEAL DISEASES; DRUG CARRIERS; EYE INFECTIONS, BACTERIAL; HUMANS;

EID: 78650821739     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2010.184259     Document Type: Editorial

References (16)

1. Fernandes M, Sridhar MS, Sangwan VS, et al. Amniotic membrane transplantation for ocular surface reconstruction. Cornea 2005;24:643-53. (Pubitemid 41060923)
2. Sangwan VS, Burman S, Tejwani S, et al. Amniotic membrane transplantation: a review of current indications in the management of ophthalmic disorders. Indian J Ophthalmol 2007;55:251-60.
3. Niknejad H, Peirovi H, Jorjani M, et al. Properties of the amniotic membrane for potential use in tissue engineering. Eur Cell Mater 2008;15:88-99.
4. King AE, Paltoo A, Kelly RW, et al. Expression of natural antimicrobials by human placenta and fetal membranes. Placenta 2007;28:161-9. (Pubitemid 44920050)
5. Ni J, Abrahamson M, Zhang M, et al. Cystatin E is a novel human cysteine proteinase inhibitor with structural resemblance to family Z cystatins. J Biol Chem 1997;272:10853-8.
6. Kim JS, Kim JC, Hahn TW, et al. Amniotic membrane transplantation in infectious corneal ulcers. Cornea 2001;20:720-6.
7. Kamal JD, Pfaller MA, Rempe LE, et al. Reduced intravascular catheter infection by antibiotic bonding: a prospective, randomized, controlled trial. JAMA 1991;265:2364-8.
8. Raad I, Darouiche R, Hachem R, et al. Antibiotics and prevention of microbial colonization of catheters. Antimicrob Agents Chemother 1995;39:2397-400.
9. Echanove JA, Edwards JR, Richards MJ, et al. Effect of nurse staffing and antimicrobial-impregnated central venous catheters on the risk for bloodstream infections in intensive care units. Infect Control Hosp Epidemiol 2003;24:916-25.
10. Eveillard M, Mertl P, Tramier B, et al. Effectiveness of gentamicin-impregnated cement in the prevention of deep wound infection after primary total knee arthroplasty. Infect Control Hosp Epidemiol 2003;24:778-80.
11. Willoughby CE, Batterbury M, Kaye SB, et al. Collagen corneal shields. Survey Ophthalmol 2002;47:174-82.
12. Friedberg ML, Pleyer U, Mondino BJ. Device drug delivery to the eye. Ophthalmology 1991;98:725-32.
13. Heiligenhaus A, Li H, Hernandez Galindo EE, et al. Management of acute ulcerative and necrotizing herpes simplex and zoster keratitis with amniotic membrane transplantation. Br J Ophthalmol 2003;87:1215-19. (Pubitemid 37193908)
14. Mencucci R, Menchini U, Dei R. Antimicrobial activity of antibiotic-treated amniotic membrane: an in vitro study. Cornea 2006;25:428-31. (Pubitemid 44620127)
15. Mencucci R, Paladini I, Menchini U, et al. Inhibition of viral replication in vitro by antiviral-treated amniotic membrane. Possible use of amniotic membrane as drug-delivering tool. Br J Ophthalmol 2011;95:28-31.
16. Heiligenhaus A, Li HF, Yang Y, et al. Transplantation of amniotic membrane in murine herpes stromal keratitis modulates matrix metalloproteinases in the cornea. Invest Ophthalmol Vis Sci 2005;46:4079-85.